Randomized Trialhigh evidence

Remission of impaired glucose tolerance by anthocyanin supplementation: a randomized, double-blind, and placebo-controlled trial.

The American journal of clinical nutrition·March 1, 2026·PMID 41619973

Why it matters

IGT reversal is a key target for preventing type 2 diabetes, and nutritional strategies are widely sought. This trial provides evidence that anthocyanin supplementation may enhance insulin sensitivity and promote regression to normoglycemia, offering a potential adjunctive dietary approach for patients with prediabetes.

Infographic summary of Remission of impaired glucose tolerance by anthocyanin supplementation: a randomized, double-blind, and placebo-controlled trial.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled